Cargando…

Association between genomic recurrence risk and well-being among breast cancer patients

BACKGROUND: Gene expression profiling (GEP) is increasingly used in the rapidly evolving field of personalized medicine. We sought to evaluate the association between GEP-assessed of breast cancer recurrence risk and patients’ well-being. METHODS: Participants were Dutch women from 10 hospitals bein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Retèl, Valesca P, Groothuis-Oudshoorn, Catharina GM, Aaronson, Neil K, Brewer, Noel T, Rutgers, Emiel JT, van Harten, Wim H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689597/ https://www.ncbi.nlm.nih.gov/pubmed/23777535 http://dx.doi.org/10.1186/1471-2407-13-295

Ejemplares similares

Scenario drafting to anticipate future developments in technology assessment
por: Retèl, Valesca P, et al.
Publicado: (2012)

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists
por: Byng, Danalyn, et al.
Publicado: (2021)

Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer
por: van de Ven, Michiel, et al.
Publicado: (2022)

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2022)

Cost-utility, cost-effectiveness, and budget impact of Internet-based cognitive behavioral therapy for breast cancer survivors with treatment-induced menopausal symptoms
por: Verbeek, Joost G. E., et al.
Publicado: (2019)

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
por: Byng, Danalyn, et al.
Publicado: (2021)

Public stated preferences and predicted uptake for genome-based colorectal cancer screening
por: Groothuis-Oudshoorn, Catharina GM, et al.
Publicado: (2014)

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients
por: Miquel-Cases, Anna, et al.
Publicado: (2016)

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness
por: Lindenberg, Melanie, et al.
Publicado: (2020)

Design of a randomized controlled trial of Internet-based cognitive behavioral therapy for treatment-induced menopausal symptoms in breast cancer survivors
por: Atema, Vera, et al.
Publicado: (2016)

Affordable Prices Without Threatening the Oncological R&D Pipeline—An Economic Experiment on Transparency in Price Negotiations
por: Franzen, Nora, et al.
Publicado: (2022)

Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group
por: Rutgers, Emiel JT, et al.
Publicado: (2004)

Toward Patient-Centered Telerehabilitation Design: Understanding Chronic Pain Patients’ Preferences for Web-Based Exercise Telerehabilitation Using a Discrete Choice Experiment
por: Cranen, Karlijn, et al.
Publicado: (2017)

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation
por: Verbeek, Joost G. E., et al.
Publicado: (2023)

Whole genome sequencing in oncology: using scenario drafting to explore future developments
por: van de Ven, Michiel, et al.
Publicado: (2021)

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes
por: Lindenberg, Melanie A., et al.
Publicado: (2022)

Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis
por: van Amerongen, Rosa A, et al.
Publicado: (2016)

Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product
por: Lindenberg, Melanie A., et al.
Publicado: (2018)

Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany
por: Voelkel, Vinzenz, et al.
Publicado: (2019)

Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L
por: Karim, Suzana, et al.
Publicado: (2022)

eHealth for Breast Cancer Survivors: Use, Feasibility and Impact of an Interactive Portal
por: Kuijpers, Wilma, et al.
Publicado: (2016)

HElmet therapy Assessment in infants with Deformed Skulls (HEADS): protocol for a randomised controlled trial
por: van Wijk, Renske M, et al.
Publicado: (2012)

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy
por: Retèl, Valesca P, et al.
Publicado: (2011)

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room
por: Patel, Sejal, et al.
Publicado: (2020)

Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach
por: Kuijpers, Wilma, et al.
Publicado: (2015)

A Systematic Review of Web-Based Interventions for Patient Empowerment and Physical Activity in Chronic Diseases: Relevance for Cancer Survivors
por: Kuijpers, Wilma, et al.
Publicado: (2013)

Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
por: van Til, Janine, et al.
Publicado: (2020)

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment
por: Wong, Xin Yi, et al.
Publicado: (2018)

Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework
por: van Til, Janine, et al.
Publicado: (2014)

Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
por: Retèl, Valesca P., et al.
Publicado: (2018)

Evaluating the Age‐Based Recommendations for Long‐Term Follow‐Up in Breast Cancer
por: Witteveen, Annemieke, et al.
Publicado: (2020)

Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation
por: van Harten, WH, et al.
Publicado: (2016)

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology
por: van Harten, WH, et al.
Publicado: (2016)

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival
por: van Maaren, Marissa C, et al.
Publicado: (2017)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021)

A preference-based item response theory model to measure health: concept and mathematics of the multi-attribute preference response model
por: Groothuis-Oudshoorn, Catharina G. M., et al.
Publicado: (2018)

Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter Analysis
por: Draeger, Teresa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bi6m285k1pcoogd19mp6cq4ns8